BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $10,000 | -9.1% | 10,000 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | -99.5% | 10,000 | -99.5% | 0.00% | -100.0% |
| Q1 2018 | $2,050,000 | +15669.2% | 2,010,000 | +16650.0% | 0.00% | – |
| Q4 2017 | $13,000 | 0.0% | 12,000 | 0.0% | 0.00% | – |
| Q3 2017 | $13,000 | 0.0% | 12,000 | 0.0% | 0.00% | – |
| Q2 2017 | $13,000 | +550.0% | 12,000 | +500.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -99.8% | 2,000 | -99.8% | 0.00% | -100.0% |
| Q2 2016 | $997,000 | -44.1% | 896,000 | -42.5% | 0.00% | 0.0% |
| Q1 2016 | $1,784,000 | -47.8% | 1,558,000 | -41.4% | 0.00% | -50.0% |
| Q4 2015 | $3,416,000 | +6.0% | 2,658,000 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $3,224,000 | -36.9% | 2,598,000 | -22.3% | 0.00% | -50.0% |
| Q2 2015 | $5,107,000 | +2.7% | 3,342,000 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $4,973,000 | -51.0% | 3,342,000 | -61.3% | 0.00% | -57.1% |
| Q4 2014 | $10,144,000 | -15.9% | 8,629,000 | -24.2% | 0.01% | -12.5% |
| Q3 2014 | $12,056,000 | -19.2% | 11,389,000 | -21.0% | 0.01% | -20.0% |
| Q2 2014 | $14,920,000 | -5.8% | 14,424,000 | -0.3% | 0.01% | -16.7% |
| Q1 2014 | $15,847,000 | +79.5% | 14,464,000 | +73.6% | 0.01% | +100.0% |
| Q4 2013 | $8,829,000 | – | 8,334,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|